These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35264780)

  • 1. Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL.
    Sethi A; Horne CR; Fitzgibbon C; Wilde K; Davies KA; Garnish SE; Jacobsen AV; Samson AL; Hildebrand JM; Wardak A; Czabotar PE; Petrie EJ; Gooley PR; Murphy JM
    Cell Death Differ; 2022 Sep; 29(9):1804-1815. PubMed ID: 35264780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis.
    Davies KA; Tanzer MC; Griffin MDW; Mok YF; Young SN; Qin R; Petrie EJ; Czabotar PE; Silke J; Murphy JM
    Cell Death Differ; 2018 Sep; 25(9):1567-1580. PubMed ID: 29445128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of MLKL membrane translocation as a checkpoint in necroptotic cell death using Monobodies.
    Petrie EJ; Birkinshaw RW; Koide A; Denbaum E; Hildebrand JM; Garnish SE; Davies KA; Sandow JJ; Samson AL; Gavin X; Fitzgibbon C; Young SN; Hennessy PJ; Smith PPC; Webb AI; Czabotar PE; Koide S; Murphy JM
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8468-8475. PubMed ID: 32234780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death.
    Hildebrand JM; Tanzer MC; Lucet IS; Young SN; Spall SK; Sharma P; Pierotti C; Garnier JM; Dobson RC; Webb AI; Tripaydonis A; Babon JJ; Mulcair MD; Scanlon MJ; Alexander WS; Wilks AF; Czabotar PE; Lessene G; Murphy JM; Silke J
    Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15072-7. PubMed ID: 25288762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis.
    Meng Y; Davies KA; Fitzgibbon C; Young SN; Garnish SE; Horne CR; Luo C; Garnier JM; Liang LY; Cowan AD; Samson AL; Lessene G; Sandow JJ; Czabotar PE; Murphy JM
    Nat Commun; 2021 Nov; 12(1):6783. PubMed ID: 34811356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionary divergence of the necroptosis effector MLKL.
    Tanzer MC; Matti I; Hildebrand JM; Young SN; Wardak A; Tripaydonis A; Petrie EJ; Mildenhall AL; Vaux DL; Vince JE; Czabotar PE; Silke J; Murphy JM
    Cell Death Differ; 2016 Jul; 23(7):1185-97. PubMed ID: 26868910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necroptosis signalling is tuned by phosphorylation of MLKL residues outside the pseudokinase domain activation loop.
    Tanzer MC; Tripaydonis A; Webb AI; Young SN; Varghese LN; Hall C; Alexander WS; Hildebrand JM; Silke J; Murphy JM
    Biochem J; 2015 Oct; 471(2):255-65. PubMed ID: 26283547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis.
    Petrie EJ; Sandow JJ; Jacobsen AV; Smith BJ; Griffin MDW; Lucet IS; Dai W; Young SN; Tanzer MC; Wardak A; Liang LY; Cowan AD; Hildebrand JM; Kersten WJA; Lessene G; Silke J; Czabotar PE; Webb AI; Murphy JM
    Nat Commun; 2018 Jun; 9(1):2422. PubMed ID: 29930286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization.
    Meng Y; Garnish SE; Davies KA; Black KA; Leis AP; Horne CR; Hildebrand JM; Hoblos H; Fitzgibbon C; Young SN; Dite T; Dagley LF; Venkat A; Kannan N; Koide A; Koide S; Glukhova A; Czabotar PE; Murphy JM
    Nat Commun; 2023 Oct; 14(1):6804. PubMed ID: 37884510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis.
    Garnish SE; Meng Y; Koide A; Sandow JJ; Denbaum E; Jacobsen AV; Yeung W; Samson AL; Horne CR; Fitzgibbon C; Young SN; Smith PPC; Webb AI; Petrie EJ; Hildebrand JM; Kannan N; Czabotar PE; Koide S; Murphy JM
    Nat Commun; 2021 Apr; 12(1):2211. PubMed ID: 33850121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis.
    Davies KA; Czabotar PE; Murphy JM
    Curr Opin Struct Biol; 2024 Oct; 88():102891. PubMed ID: 39059047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral MLKL Homologs Subvert Necroptotic Cell Death by Sequestering Cellular RIPK3.
    Petrie EJ; Sandow JJ; Lehmann WIL; Liang LY; Coursier D; Young SN; Kersten WJA; Fitzgibbon C; Samson AL; Jacobsen AV; Lowes KN; Au AE; Jousset Sabroux H; Lalaoui N; Webb AI; Lessene G; Manning G; Lucet IS; Murphy JM
    Cell Rep; 2019 Sep; 28(13):3309-3319.e5. PubMed ID: 31553902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells.
    Samson AL; Fitzgibbon C; Patel KM; Hildebrand JM; Whitehead LW; Rimes JS; Jacobsen AV; Horne CR; Gavin XJ; Young SN; Rogers KL; Hawkins ED; Murphy JM
    Cell Death Differ; 2021 Jul; 28(7):2126-2144. PubMed ID: 33589776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct pseudokinase domain conformations underlie divergent activation mechanisms among vertebrate MLKL orthologues.
    Davies KA; Fitzgibbon C; Young SN; Garnish SE; Yeung W; Coursier D; Birkinshaw RW; Sandow JJ; Lehmann WIL; Liang LY; Lucet IS; Chalmers JD; Patrick WM; Kannan N; Petrie EJ; Czabotar PE; Murphy JM
    Nat Commun; 2020 Jun; 11(1):3060. PubMed ID: 32561735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human RIPK3 C-lobe phosphorylation is essential for necroptotic signaling.
    Meng Y; Horne CR; Samson AL; Dagley LF; Young SN; Sandow JJ; Czabotar PE; Murphy JM
    Cell Death Dis; 2022 Jun; 13(6):565. PubMed ID: 35739084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.
    Murphy JM; Czabotar PE; Hildebrand JM; Lucet IS; Zhang JG; Alvarez-Diaz S; Lewis R; Lalaoui N; Metcalf D; Webb AI; Young SN; Varghese LN; Tannahill GM; Hatchell EC; Majewski IJ; Okamoto T; Dobson RC; Hilton DJ; Babon JJ; Nicola NA; Strasser A; Silke J; Alexander WS
    Immunity; 2013 Sep; 39(3):443-53. PubMed ID: 24012422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndrome.
    Yu X; Mao M; Liu X; Shen T; Li T; Yu H; Zhang J; Chen X; Zhao X; Zhu D
    J Mol Med (Berl); 2020 Apr; 98(4):569-583. PubMed ID: 32072232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis.
    Rodriguez DA; Weinlich R; Brown S; Guy C; Fitzgerald P; Dillon CP; Oberst A; Quarato G; Low J; Cripps JG; Chen T; Green DR
    Cell Death Differ; 2016 Jan; 23(1):76-88. PubMed ID: 26024392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential Engagement of Distinct MLKL Phosphatidylinositol-Binding Sites Executes Necroptosis.
    Quarato G; Guy CS; Grace CR; Llambi F; Nourse A; Rodriguez DA; Wakefield R; Frase S; Moldoveanu T; Green DR
    Mol Cell; 2016 Feb; 61(4):589-601. PubMed ID: 26853145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors identify an auxiliary role for mTOR signalling in necroptosis execution downstream of MLKL activation.
    Garnish SE; Horne CR; Meng Y; Young SN; Jacobsen AV; Hildebrand JM; Murphy JM
    Biochem J; 2024 Sep; 481(17):1125-1142. PubMed ID: 39136677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.